Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 13/20 | 0.74 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.68 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.66 |
| ▸ | MAOA | P21397 | 2/20 | 0.65 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.57 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.56 |
| ▸ | GRM5 | P41594 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2088282 | 0.85 | MAOB (1.00) | MAOBNR4A2PARP10MAOAGRM5 | |
| SCHEMBL5044914 | 0.82 | NR4A2 (0.63) | MAOBNR4A2PARP10MAOASCN9A | |
| SCHEMBL9626407 | 0.82 | MAOB (0.69) | MAOBNR4A2PARP10MAOASCN9A | |
| SCHEMBL3625818 | 0.81 | MAOB (0.73) | MAOBNR4A2PARP10MAOA | |
| SCHEMBL1068959 | 0.81 | MAOB (0.70) | MAOBNR4A2PARP10FFAR1 | |
| SCHEMBL27521276 | 0.81 | MAOB (0.77) | MAOBNR4A2PARP10MAOA | |
| SCHEMBL7026306 | 0.81 | MAOB (0.74) | MAOBMAOA | |
| SCHEMBL2195021 | 0.81 | NR4A2 (1.00) | MAOBNR4A2PARP10 | |
| SCHEMBL31591490 | 0.81 | NR4A2 (1.00) | MAOBNR4A2PARP10 | |
| SCHEMBL2196098 | 0.80 | MAOB (0.75) | MAOBNR4A2PARP10MAOASCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005009104-A2 | BENZOIC AND PHENYL ACETIC ACID DERIVATIVES AS HNF-4 MODULATORS | LIGAND PHARMACUETICALS INCORPORATED (US) | 2005-02-03 | — | — | WO | claimed |
| WO-2005009104-A2 | BENZOIC AND PHENYL ACETIC ACID DERIVATIVES AS HNF-4 MODULATORS | LIGAND PHARMACUETICALS INCORPORATED (US) | 2005-02-03 | — | — | WO | disclosed |